524735 Stock Overview
Manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 4/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 4/6 |
Community vs My Fair Value
Create NarrativeSelect a narrative for quick price alerts from the community, or create your own.
New Panoli Facility And Global Expansions Will Strengthen Operations Over Next 2-3 Years
My Notes
Capture your thoughts, links and company narrative
Hikal Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₹357.80 |
| 52 Week High | ₹464.50 |
| 52 Week Low | ₹260.65 |
| Beta | 1.29 |
| 1 Month Change | -1.13% |
| 3 Month Change | -8.43% |
| 1 Year Change | 26.05% |
| 3 Year Change | -4.17% |
| 5 Year Change | 175.55% |
| Change since IPO | 34,902.28% |
Recent News & Updates
Recent updates
Shareholder Returns
| 524735 | IN Pharmaceuticals | IN Market | |
|---|---|---|---|
| 7D | 4.5% | -2.2% | -0.7% |
| 1Y | 26.1% | 9.4% | -0.6% |
Return vs Industry: 524735 exceeded the Indian Pharmaceuticals industry which returned 9.4% over the past year.
Return vs Market: 524735 exceeded the Indian Market which returned -0.6% over the past year.
Price Volatility
| 524735 volatility | |
|---|---|
| 524735 Average Weekly Movement | 6.4% |
| Pharmaceuticals Industry Average Movement | 6.7% |
| Market Average Movement | 6.6% |
| 10% most volatile stocks in IN Market | 9.4% |
| 10% least volatile stocks in IN Market | 4.4% |
Stable Share Price: 524735 has not had significant price volatility in the past 3 months compared to the Indian market.
Volatility Over Time: 524735's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1988 | 2,061 | Sameer Hiremath | www.hikal.com |
Hikal Limited, together with its subsidiaries, manufactures and sells various chemical intermediates, specialty chemicals, and active pharma ingredients to pharmaceutical, animal health, biotech, crop protection, and specialty chemicals companies in India, the United States, Canada, Europe, South East Asia, and internationally. It operates through two segments, Pharmaceuticals and Crop Protection. The Pharmaceuticals segment produces active pharmaceutical ingredients (APIs).
Hikal Limited Fundamentals Summary
| 524735 fundamental statistics | |
|---|---|
| Market cap | ₹43.78b |
| Earnings (TTM) | ₹746.02m |
| Revenue (TTM) | ₹18.22b |
59.1x
P/E Ratio2.4x
P/S RatioIs 524735 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 524735 income statement (TTM) | |
|---|---|
| Revenue | ₹18.22b |
| Cost of Revenue | ₹9.06b |
| Gross Profit | ₹9.16b |
| Other Expenses | ₹8.41b |
| Earnings | ₹746.02m |
Last Reported Earnings
Dec 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 6.05 |
| Gross Margin | 50.28% |
| Net Profit Margin | 4.10% |
| Debt/Equity Ratio | 64.4% |
How did 524735 perform over the long term?
See historical performance and comparisonDividends
0.3%
Current Dividend Yield20%
Payout RatioDoes 524735 pay a reliable dividends?
See 524735 dividend history and benchmarks| Hikal dividend dates | |
|---|---|
| Ex Dividend Date | Feb 07 2025 |
| Dividend Pay Date | Mar 05 2025 |
| Days until Ex dividend | 15 days |
| Days until Dividend pay date | 11 days |
Does 524735 pay a reliable dividends?
See 524735 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/21 12:08 |
| End of Day Share Price | 2025/02/21 00:00 |
| Earnings | 2024/12/31 |
| Annual Earnings | 2024/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Hikal Limited is covered by 3 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Rohit Bhat | Batlivala & Karani Securities India Pvt. Ltd. |
| Kameswari V. S. Chavali | FirstCall Research |
| Siddhant Khandekar | ICICIdirect.com |